Pharmacist-Partnered Tapering

Uses

How it works

Dosage & preparation

Preparation

Highlighted claims

• The intervention adds pharmacist-partnered opioid tapering by telehealth to standard care. — Responsible preoperative opioid use for hip or knee arthroplasty (OpioidHALT): a protocol for a randomised clinical trial of pharmacist-partnered opioid tapering prior to hip or knee arthroplasty
• The pharmacist uses shared decision-making to create an individualised biopsychosocial pain management plan and opioid weaning plan. — Responsible preoperative opioid use for hip or knee arthroplasty (OpioidHALT): a protocol for a randomised clinical trial of pharmacist-partnered opioid tapering prior to hip or knee arthroplasty
• The intervention lasts about 3 months before surgery, with dose reductions continuing where possible until surgery. — Responsible preoperative opioid use for hip or knee arthroplasty (OpioidHALT): a protocol for a randomised clinical trial of pharmacist-partnered opioid tapering prior to hip or knee arthroplasty
• Before tapering starts, the pharmacist contacts the participant's GP to explain the intervention and address concerns. — Responsible preoperative opioid use for hip or knee arthroplasty (OpioidHALT): a protocol for a randomised clinical trial of pharmacist-partnered opioid tapering prior to hip or knee arthroplasty
• All intervention participants receive an evidence-based NPS MedicineWise opioid tapering plan to guide tapering rates. — Responsible preoperative opioid use for hip or knee arthroplasty (OpioidHALT): a protocol for a randomised clinical trial of pharmacist-partnered opioid tapering prior to hip or knee arthroplasty
• The intervention's behaviour change framework targets capability, opportunity and motivation. — Responsible preoperative opioid use for hip or knee arthroplasty (OpioidHALT): a protocol for a randomised clinical trial of pharmacist-partnered opioid tapering prior to hip or knee arthroplasty